Healthcare provider profile · identity verified

Nelson Jaco

Nurse Practitioner · HYDE PARK, UT · NPI 1457948374

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	510	150
Omeprazole	Omeprazole	296	76
Lisinopril	Lisinopril	247	84
Losartan Potassium	Losartan Potassium	230	56
Amlodipine Besylate	Amlodipine Besylate	218	59
Hydrochlorothiazide	Hydrochlorothiazide	214	55
Levothyroxine Sodium	Levothyroxine Sodium	153	46
Trazodone Hcl	Trazodone Hcl	149	26
Rosuvastatin Calcium	Rosuvastatin Calcium	140	48
Duloxetine Hcl	Duloxetine Hcl	110	31
Metformin Hcl Er	Metformin Hcl	88	29
Carvedilol	Carvedilol	85	23
Fluoxetine Hcl	Fluoxetine Hcl	81	13
Tamsulosin Hcl	Tamsulosin Hcl	81	28
Potassium Chloride	Potassium Chloride	78	16
Metformin Hcl	Metformin Hcl	75	17
Pioglitazone Hcl	Pioglitazone Hcl	71	24
Metoprolol Succinate	Metoprolol Succinate	68	16
Xarelto	Rivaroxaban	64	12
Furosemide	Furosemide	61	15
Montelukast Sodium	Montelukast Sodium	58	17
Lamotrigine	Lamotrigine	57	suppressed
Olanzapine	Olanzapine	54	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	54	suppressed
Amantadine	Amantadine Hcl	53	suppressed
Trulicity	Dulaglutide	52	suppressed
Ozempic	Semaglutide	51	suppressed
Tramadol Hcl	Tramadol Hcl	51	11
Allopurinol	Allopurinol	50	14
Sertraline Hcl	Sertraline Hcl	48	15
Gabapentin	Gabapentin	45	22
Metoprolol Tartrate	Metoprolol Tartrate	44	11
Pantoprazole Sodium	Pantoprazole Sodium	43	19
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Simvastatin	Simvastatin	37	12
Amitriptyline Hcl	Amitriptyline Hcl	36	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	14
Escitalopram Oxalate	Escitalopram Oxalate	35	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	32
Spironolactone	Spironolactone	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	33	33
Pregabalin	Pregabalin	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	19
Bupropion Xl	Bupropion Hcl	29	suppressed
Cephalexin	Cephalexin	29	25
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	21
Amoxicillin	Amoxicillin	28	27
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	11
Celecoxib	Celecoxib	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Finasteride	Finasteride	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Eliquis	Apixaban	21	suppressed
Ibuprofen	Ibuprofen	21	14
Donepezil Hcl	Donepezil Hcl	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Alprazolam	Alprazolam	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	12
Alendronate Sodium	Alendronate Sodium	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Cefdinir	Cefdinir	15	15
Chlorthalidone	Chlorthalidone	14	suppressed
Estradiol	Estradiol	14	suppressed
Famotidine	Famotidine	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error